Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety
Adam C. Mirando, Raquel Lima e Silva, Jikui Shen, Thomas J. Robinson, Jordan J. Green, Peter A. Campochiaro, Aleksander S. Popel, Niranjan B. Pandey
This study evaluates suprachoroidal delivery of AXT107 microparticles for treating retinal and choroidal vascular diseases, showing reduced neovascularization and favorable safety.
bioRxiv · Jul 5, 2026 · PreprintPharmacology & Toxicology